4//SEC Filing
WIERENGA WENDALL 4
Accession 0000950170-25-086260
CIK 0001658247other
Filed
Jun 12, 8:00 PM ET
Accepted
Jun 13, 4:30 PM ET
Size
7.4 KB
Accession
0000950170-25-086260
Insider Transaction Report
Form 4
WIERENGA WENDALL
Director
Transactions
- Award
Common Stock
2025-06-11+6,900→ 116,146 total - Award
Stock Option (right to buy)
2025-06-11+10,350→ 10,350 totalExercise: $32.33Exp: 2035-06-11→ Common Stock (10,350 underlying)
Footnotes (2)
- [F1]The transaction reported on this line involves the receipt of restricted stock units, which represent the right to receive shares of the Issuer's Common Stock, with 100% vesting on the earlier of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date.
- [F2]The stock option shall vest and become exercisable on the earlier of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date.
Documents
Issuer
Crinetics Pharmaceuticals, Inc.
CIK 0001658247
Entity typeother
Related Parties
1- filerCIK 0001235945
Filing Metadata
- Form type
- 4
- Filed
- Jun 12, 8:00 PM ET
- Accepted
- Jun 13, 4:30 PM ET
- Size
- 7.4 KB